Respiratory Infections

An assessment observing 4 states under stay-at-home orders showed all avoided worsened outcomes of severe infection rates.

Clinicians and researchers have questioned the likelihood of assembling the quantity of data supplied by Surgisphere on hydroxychloroquine in such a short period of time.

A brief on the latest infectious disease headlines.

The test measures IL-6 to identify patients with COVID-19 at high risk of intubation.

About two-thirds of patients that reported loss of smell associated with viral infection actually had confirmed anosmia after objective olfactory testing.

Though most trace the coronavirus outbreak to China, a new analysis finds most of the cases in New York seem to have originated in Europe.

The trial consisted of non-hospitalized adults who indicated a high-risk or moderate-risk exposure to COVID-19 through the household or an occupational setting.

John Strotbeck, Olympian and CEO of Boathouse Sports, explains how and why the outerwear company pivoted to PPE production at the start of the COVID-19 pandemic.

An eventual COVID-19 vaccination should be prepared to face obstacles before distribution, so the groundwork for factual information dissemination should begin now.

While COVID-19 may have impacted flu-like illness reporting, the CDC estimates there were between 24,000-62,000 related deaths this year.

A study team investigated the ideal physical distance for avoiding SARS-CoV-2 transmission and assessed the use of eye protection and face coverings in preventing acquisition.

Denise Bascow, MD, describes a platform for keeping up to date with the latest clinical information.

A look at the means by which clinicians are quantifying and evaluating the effects of the antiviral drug.

New findings from the CDC show community transmission may have begun in the Pacific Northwest a full month before the first confirmed case.

It's been one month since the antiviral therapy was granted emergency use authorization. How has it affected COVID-19 care?

A daily infectious disease news update

Investigators sought to summarize evidence about the benefits and harms of hydroxychloroquine and chloroquine as treatments or prophylaxis of COVID-19.

A new report outlines the proven steps needed to implement a national strategy for SARS-CoV-2 screening.

A brief on our top stories from May 28, 2020.

Collected specimens can be tested with the Quest Diagnostics SARS-CoV-2 RT-PCR test to have received EUA from the FDA earlier in March.

Debbie Goff, PharmD, describes how antimicrobial stewardship work has continued during the COVID-19 pandemic.

Less ACE2 in nasal epithelium in children could present barrier to SARS-CoV-2 and explain the lower observed rate of pediatric infections.

An assessment of severe coronavirus patients administered either five-day or 10-day remdesivir treatment shows benefit is fairly similar, regardless of duration.

A new paper analyzed cancer types to determine which types of cancer put a patient at highest risk of contracting coronavirus.

A daily news update on our COVID-19 coverage.

Clinicians should be wary of risk for depression, anxiety, fatigue, PTSD, and, potentially, rare neuropsychiatric syndromes, in post-coronavirus patients.

While not without its challenges, converting a pediatric intensive care unit to care for adult novel coronavirus patients was the right decision for the Mass General Hospital for Children.

Executive members of coronavirus therapy candidate global assessment came to decision after new data showed the therapy was linked to increased mortality and cardiovascular event risk.

Preliminary results were highly anticipated, given Anthony Fauci, MD, made optimistic statements about the drug in late April.

An analysis by health officials in the UK shows patients in the community (as opposed to the hospital) who were tested for coronavirus had the highest rate of positive results.